Chemotherapy Improves Survival in Older Patients With NSCLC
Use of chemotherapy among patients aged 80 years and older with metastatic non-small cell lung cancer (NSCLC) was linked to longer overall survival.
Lung Cancer
Opdivo No Longer FDA-Approved for Small Cell Lung Cancer
In 2018, the FDA granted accelerated approval to Opdivo for SCLC based on data from the phase 1/2 CheckMate -032 trial.
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
A deep learning model based on chest radiograph images and electronic medical record data shows promise for smokers at high risk for lung cancer
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
USPSTF recommends annual low-dose computed tomography screening for people aged 50 to 80 years at high lung cancer risk due to smoking history.
Adherence to USPSTF Lung Cancer Screening Recommendations
12.5 percent of those meeting USPSTF recommendations for low-dose CT had screening exam in past year.
Current Lung Cancer Screening Guidelines Suboptimal in Identifying At-Risk Women
Current US Preventive Services Task Force guidelines are not applicable to most women at risk for lung cancer.
Common TB Vaccine Associated With Lower Lung Cancer Rates
In 60-year follow-up, significantly lower lung cancer rates seen for those with childhood BCG vaccination.
High Fiber, Yogurt Intake Linked to Reduced Risk for Lung Cancer
Dietary fiber and yogurt consumption are associated with a reduced risk for lung cancer.
Increasing USPSTF Lung Cancer Screening Eligibility in African American Smokers
Lowering the USPSTF smoking pack-year lung cancer screening criteria to a minimum 20-pack-year history may increase the number of African American smokers who are screened.
Rates of Lung Cancer Screening Discussions Low Between Physicians and Patients
The rate of discussions between physicians and patients regarding lung cancer screenings is very low.
- Loading...
Loading...
Next post in Pulmonology Information Center
Loading... 
Loading...